Rifabutin-Based Triple Therapy for Helicobacter pylori

2558 โดย first-line therapy ได้แก่ standard triple therapy, sequential therapy, concomitant quadruple therapy และ second-line therapy ได้แก่ quadruple

As H pylori rescue treatment, rifabutin-containing triple therapy was comparable to bismuth quadruple therapy and associated with fewer AEs

triple h A levofloxacin–amoxycillin-based triple therapy has been proved to be an acceptably effective second-line therapy for H pylori infection, but the role of

triple therapy A combination of RBC with clarithromycin has resulted in eradication rates in the range of 72% to 80%, comparable to those of triple antibiotic therapy Dual